東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Novel therapeutics for rare lymphomas

Dittus, Christopher.

Linked to FindBook

Google Book

Amazon

博客來

Novel therapeutics for rare lymphomas

Record Type:	Electronic resources : Monograph/item
Title/Author:	Novel therapeutics for rare lymphomas/ edited by Christopher Dittus.
other author:	Dittus, Christopher.
Published:	Cham :Springer International Publishing : : 2020.,
Description:	x, 253 p. :ill. (some col.), digital ;24 cm.
[NT 15003449]:	The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.
Contained By:	Springer eBooks
Subject:	Lymphomas - Treatment. -
Online resource:	https://doi.org/10.1007/978-3-030-25610-4
ISBN:	9783030256104

Novel therapeutics for rare lymphomas
Novel therapeutics for rare lymphomas[electronic resource] /edited by Christopher Dittus. - Cham :Springer International Publishing :2020. - x, 253 p. :ill. (some col.), digital ;24 cm.

The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

ISBN: 9783030256104

Standard No.: 10.1007/978-3-030-25610-4doiSubjects--Topical Terms:

1359574
Lymphomas
--Treatment.

LC Class. No.: RC280.L9

Dewey Class. No.: 616.99446

Novel therapeutics for rare lymphomas
LDR:02457nmm a2200325 a 4500 001 2214298
003 DE-He213
005 20200304115441.0
006 m d
007 cr nn 008maaau
008 201118s2020 gw s 0 eng d
020 $a 9783030256104 $q (electronic bk.)
020 $a 9783030256098 $q (paper)
024 7 $a 10.1007/978-3-030-25610-4 $2 doi
035 $a 978-3-030-25610-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L9
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99446 $2 23
090 $a RC280.L9 $b N937 2020
245 0 0 $a Novel therapeutics for rare lymphomas $h [electronic resource] / $c edited by Christopher Dittus.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 253 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.
520 $a This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
650 0 $a Lymphomas $x Treatment. $3 1359574
650 1 4 $a Oncology. $3 751006
650 2 4 $a Hematology. $3 808260
700 1 $a Dittus, Christopher. $3 3444630
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-25610-4
950 $a Medicine (Springer-11650)